The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
Clinical trial NCT01088165 · UNKNOWN
Trial details
- NCT number
- NCT01088165
- Sponsor
- Medical University of Vienna
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.